Healthcare -
Biotechnology - NASDAQ - US
$ 1.39
-2.11 %
$ 161 M
Market Cap
-15.44
P/E
Price Target
Average
439.57%
Revenue Forecast
Estimate
8.09%
EBIT
Estimate
14.54%
Net Income
Estimate
36.73%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Coherus BioSciences, Inc.
Wall Street analysts predict an average 1-year price target for CHRS of $7.5 , with forecasts ranging from
a
low of
$6 to a high of $11 .
CHRS Lowest Price Target
Wall Street Target
6 USD
331.65%
CHRS Average Price Target
Wall Street Target
7.5 USD
439.57%
CHRS Highest Price Target
Wall Street Target
11 USD
691.37%
REVENUE FORECAST
Revenue Forecast Chart CHRS
EBIT FORECAST
EBIT Forecast Chart CHRS
NET INCOME FORECAST
Net Income Chart CHRS